Hanzhong Liu

Ying Wu, Hanzhong Liu, Kai Ren et al.

Interpretability plays a crucial role in the application of statistical learning to estimate heterogeneous treatment effects (HTE) in complex diseases. In this study, we leverage a rule-based workflow, namely causal rule learning (CRL), to estimate and improve our understanding of HTE for atrial septal defect, addressing an overlooked question in the previous literature: what if an individual simultaneously belongs to multiple groups with different average treatment effects? The CRL process consists of three steps: rule discovery, which generates a set of causal rules with corresponding subgroup average treatment effects; rule selection, which identifies a subset of these rules to deconstruct individual-level treatment effects as a linear combination of subgroup-level effects; and rule analysis, which presents a detailed procedure for further analyzing each selected rule from multiple perspectives to identify the most promising rules for validation. Extensive simulation studies and real-world data analysis demonstrate that CRL outperforms other methods in providing interpretable estimates of HTE, especially when dealing with complex ground truth and sufficient sample sizes.

Yizhi Wang, Li Chen, Qiang Huang et al.

Cervical cancer remains a major malignancy, necessitating extensive and complex histopathological assessments and comprehensive support tools. Although deep learning shows promise, these models still lack accuracy and generalizability. General foundation models offer a broader reach but remain limited in capturing subspecialty-specific features and task adaptability. We introduce the Cervical Subspecialty Pathology (CerS-Path) diagnostic system, developed through two synergistic pretraining stages: self-supervised learning on approximately 190 million tissue patches from 140,000 slides to build a cervical-specific feature extractor, and multimodal enhancement with 2.5 million image-text pairs, followed by integration with multiple downstream diagnostic functions. Supporting eight diagnostic functions, including rare cancer classification and multimodal Q&A, CerS-Path surpasses prior foundation models in scope and clinical applicability. Comprehensive evaluations demonstrate a significant advance in cervical pathology, with prospective testing on 3,173 cases across five centers maintaining 99.38% screening sensitivity and excellent generalizability, highlighting its potential for subspecialty diagnostic translation and cervical cancer screening.